Cannabis and first-episode psychosis: Different long-term outcomes depending on continued or discontinued use

Schizophrenia Bulletin

Volumn 37, Issue 3, 2011, Pages 631-639

  González Pinto, Ana ^a   Alberich, Susana ^a   Barbeito, Sara ^a   Gutierrez, Miguel ^a   Vega, Patricia ^a   Ibáñez, Berta ^b   Haidar, Mahmoud Karim ^a   Vieta, Eduard ^c   Arango, Celso ^d  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

cannabis; discontinued use; first episode psychosis; follow up; outcome

Indexed keywords

CANNABIS;

ADULT; ALCOHOL ABUSE; ARTICLE; CANNABIS ADDICTION; CONTROLLED STUDY; DRUG ABUSE; EFFECT SIZE; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSIS;

ADULT; CANNABIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PLANT PREPARATIONS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955442545     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbp126     Document Type: Article

References (35)

1. Kendler KSM, Schmitt EB, Aggen S, Prescott CA. Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch Gen Psychiatry. 2008;65:674-682. (Pubitemid 351787238)
2. Veen ND, Selten JP, van der Tweel I, Feller WG, Hoek HW, Kahn RS. Cannabis use and age at onset of schizophrenia. Am J Psychiatry. 2004;161:501-516.
3. Gonzalez-Pinto A, Vega P, Ibañez B, et al. Impact of cannabis and other drugs on age at onset of psychosis. J Clin Psychiatry. 2008;69:1210-1216.
4. Henquet C, Murray R, Linszen D, Van OJ. The environment and schizophrenia: the role of cannabis use. Schizophr Bull. 2005;31:608-612. (Pubitemid 41253312)
5. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry. 1994;51:273-279. (Pubitemid 24127299)
6. Dekker N, de Hann L, Berq S, Gier M, Becker H, Linzen DH. Cessation of cannabis use by patients with recent-onset schizophrenia and related disorders. Psychopharmacol Bull. 2008;41(1):142-153.
7. Selten JP, Veen ND, Hoek HW, et al. Early course of schizophrenia in a representative Dutch incidence cohort. Schizophr Res. 2007;97(1-3):79-87. (Pubitemid 350088385)
8. Rais M, Cahn W, Van Haren N, et al. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry. 2008;165:490-496. (Pubitemid 351694292)
9. Zammit S, Moore TH, Lingford-Hughes A, et al. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry. 2008;193:357-363.
10. Hides LD. Psychotic symptom and cannabis relapse in recentonset psychosis: prospective study. Br J Psychiatry. 2006; 189:137-143.
11. Wade D, Harrigan S, Edwards J, Burgess PM, Whelan G, McGorry PD. Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophr Res. 2006;81(2- 3):145-150. (Pubitemid 43107688)
12. Strakowski SM, DelBello MP, Fleck DE, et al. Effects of cooccurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Arch Gen Psychiatry. 2007;64:57-64. (Pubitemid 46041739)
13. Bhattacharyya S, Fusar-Poli P, Borgwardt S, et al. Modulation of mediotemporal and ventrostriatal function in humans by Delta9- tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry. 2009;66:442-451.
14. Fusar-Poli P, Crippa JA, Bhattacharyya S, et al. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry. 2009;66:95-105.
15. Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand. 2007;115:304-309. (Pubitemid 46425747)
16. Edwards J, Elkins K, Hinton M, et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand. 2006;114:109-117. (Pubitemid 44034269)
17. Archie S, Rush BR, Akhtar-Danesh N, et al. Substance use and abuse in first-episode psychosis: prevalence before and after early intervention. Schizophr Bull. 2007;33:1354-1363. (Pubitemid 350022769)
18. Salvatore P, Baldessarini JR, Tohen M, et al. McLean-Harvard First-Episode project: two-year stability of DSM-IV diagnosis in 500 first-episode psychotic disorder patients. J Clin Psychiatry. 2009;70:458-466.
19. Baeza I, Graell M, Moreno D, et al. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophr Res. 2009;113:129-137.
20. American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders 4th ed Washington, DC: American Psychiatric Association; 1994.
21. First MB, Spitzer RL, Williams JBW, Gibbon M. SCID-I: Version 2.0 for DSM-IV. Washington, DC: American Psychiatric Press; 1997.
22. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276. (Pubitemid 18039085)
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
24. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429-435. (Pubitemid 9006756)
25. Harris JG, Jr. An abbreviated form of the Philips rating scale of premorbid adjustment in schizophrenia. J Abnorm Psychol. 1975;84:129-137.
26. Endincott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766-771.
27. Martínez-Arán A, Vieta E, Colom F, et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 2004;6:224-232. (Pubitemid 38702298)
28. R Development Core Team (2007). R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. ISBN 3-900051-07-0. http:// www.R-project.org. Accessed December 21, 2008.
29. Grech A, Van OJ, Jones PB, Lewis SW, Murray RM. Cannabis use and outcome of recent onset psychosis. Eur Psychiatry. 2005;20:349-353. (Pubitemid 40978562)
30. Casper ES, Regan JR. Reasons for admission among six profile subgroups of recidivists of inpatient services. Can J Psychiatry. 1993;38:657-661. (Pubitemid 24036910)
31. Stirling J, Lewis S, Hopkins R, White C. Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophr Res. 2005;75(1):135-137. (Pubitemid 40487981)
32. Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand. 1992; 85:127-130.
33. Luengo MA, Kulis S, Marsiglia FF, et al. A cross-national study of preadolescent substance use: exploring differences between youth in Spain and Arizona. Subst Use Misuse. 2008;43:1571-1593.
34. Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D, for the European mania in Biopolar Longitudinal Evaluation of medication (EMBLEM) Advisory Board. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania [Epub ahead of print August 25, 2009]. J Clin Psychiatry. PMID: 19709503.
35. Lieberman JA, Kane JM, Safferman AZ, et al. Predictors of response to clozapine. J Clin Psychiatry. 1994;55(suppl B):126-128. (Pubitemid 24353035)